Avidity Biosciences
RNA
#1835
Rank
ยฃ8.10 B
Marketcap
ยฃ53.77
Share price
0.13%
Change (1 day)
86.02%
Change (1 year)

Market capitalization of Avidity Biosciences (RNA)

Market cap: ยฃ8.10 Billion

As of December 2025 Avidity Biosciences has a market cap of ยฃ8.10 Billion. This makes Avidity Biosciences the world's 1835th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Avidity Biosciences from 2020 to 2025

End of year Market Cap

Year Marketcap Change
2025ยฃ8.10 B183.01%
2024ยฃ2.86 B408.97%
2023ยฃ0.56 B-53.86%
2022ยฃ1.21 B47.61%
2021ยฃ0.82 B17.54%
2020ยฃ0.70 B

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Avidity Biosciences was reported to be:

ยฃ8.10 Billion
by Nasdaq info icon info icon
ยฃ8.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
PTC Therapeutics
PTCT
ยฃ4.65 B-42.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
ยฃ0.61 M-99.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
ยฃ1.75 B-78.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
ยฃ2.17 B-73.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
ยฃ93.51 M-98.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
ยฃ8.20 B 1.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ111.09 B 1,271.26%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ73.35 B 805.40%๐Ÿ‡ฌ๐Ÿ‡ง UK